Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years

J. J. Cornelissen*, J. Versluis, J. R. Passweg, W. L. J. van Putten, M. G. Manz, J. Maertens, H. B. Bverloo, P. J. M. Valk, M. van Marwijk Kooy, P. W. Wijermans, M. R. Schaafsma, B. J. Biemond, M-C Vekemans, D. A. Breems, L. F. Verdonck, M. F. Fey, M. Jongen-Lavrencic, J. J. W. M. Janssen, G. Huls, J. KuballT. Pabst, C. Graux, H. C. Schouten, A. Gratwohl, E. Vellenga, G. Ossenkoppele, B. Loewenberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1041-1050
JournalLeukemia
Volume29
Issue number5
DOIs
Publication statusPublished - May 2015

Cite this